{
    "Trade/Device Name(s)": [
        "AmpliVue\u00ae Trichomonas Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K143329",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122062"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY"
    ],
    "Summary Letter Date": "February 18, 2015",
    "Summary Letter Received Date": "February 19, 2015",
    "Submission Date": "November 17, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "nucleic acid amplification test system"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Trichomonas vaginalis DNA"
    ],
    "Specimen Type(s)": [
        "Vaginal swab"
    ],
    "Specimen Container(s)": [
        "Lysis buffer tube",
        "Dilution buffer tube",
        "Reaction tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Isothermal amplification",
        "Helicase-dependent amplification (HDA)",
        "Lateral flow detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Cassette",
        "Cartridge",
        "Tube",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for AmpliVue\u00ae Trichomonas Assay, an HDA-based qualitative nucleic acid amplification test for Trichomonas vaginalis DNA in vaginal swabs from women.",
    "Indications for Use Summary": "Qualitative in vitro detection of Trichomonas vaginalis nucleic acids from clinician-collected vaginal swabs of symptomatic or asymptomatic females to aid in the diagnosis of trichomoniasis.",
    "fda_folder": "Immunology"
}